Literature DB >> 11900850

Characterization of the murine cytomegalovirus 38 kDa m137 gene product.

Robert J Visalli1, Jeanette Fairhurst, Subramanian Kothandaraman, Aron Buklan.   

Abstract

Murine cytomegalovirus (MCMV) m137 null mutants, Deltam137A and Deltam137B, were generated by inserting a gpt cassette into a deleted region of the open reading frame. A polyclonal antiserum produced to an Escherichia coli expressed gst-m137 fusion protein was used to show that a 38 kDa polypeptide corresponding to the predicted m137 gene product was present in NIH 3T3 fibroblasts infected with wild-type MCMV but was not detected in Deltam137 infected cells. The protein did not fractionate with infected cell membranes and was not detectable in purified wild-type virions. Plaque size, plaque morphology, and viral yield did not differ significantly between Deltam137 and wild-type MCMV infected 3T3 fibroblasts. The results showed that deletion of the 38 kDa protein did not negatively effect viral growth in 3T3 fibroblasts indicating that the m137 gene product is not essential for replication in these cells. In vivo analysis revealed that two independently isolated m137 mutants showed a significant delay in time until death but ultimately killed 100% of the mice in a SCID mouse model of virulence.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11900850     DOI: 10.1016/s0168-1702(02)00024-2

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  2 in total

1.  Characterization of the murine cytomegalovirus m136 gene.

Authors:  Robert J Visalli; Denise M Nicolosi; Karen Irven; Tamseel Khan; Melissa A Visalli
Journal:  Virus Genes       Date:  2006-12-02       Impact factor: 2.332

2.  Herpes simplex virus type 2 UL24 gene is a virulence determinant in murine and guinea pig disease models.

Authors:  Susan Blakeney; Jacek Kowalski; Donna Tummolo; Joanne DeStefano; David Cooper; Min Guo; Seema Gangolli; Deborah Long; Timothy Zamb; Robert J Natuk; Robert J Visalli
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.